New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment DOI Creative Commons
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova

и другие.

Molecules, Год журнала: 2024, Номер 29(22), С. 5314 - 5314

Опубликована: Ноя. 11, 2024

Alzheimer's disease (AD) involves a complex pathophysiology with multiple interconnected subpathologies, including protein aggregation, impaired neurotransmission, oxidative stress, and microglia-mediated neuroinflammation. Current treatments, which generally target single subpathology, have failed to modify the disease's progression, providing only temporary symptom relief. Multi-target drugs (MTDs) address several aggregation of pathological proteins. In this review, we cover hybrid molecules published between 2014 2024. We offer an overview strategies employed in drug design approaches that led notable improvements reduced hepatotoxicity. Our aim is insights into potential development new drugs. This highlights multi-target featuring heterocycles

Язык: Английский

Nutrition: A non‐negligible factor in the pathogenesis and treatment of Alzheimer's disease DOI Creative Commons

Boye Wen,

Xiaodong Han,

Jin Gong

и другие.

Alzheimer s & Dementia, Год журнала: 2025, Номер unknown

Опубликована: Янв. 27, 2025

Abstract Alzheimer's disease (AD) is a degenerative characterized by progressive cognitive dysfunction. The strong link between nutrition and the occurrence progression of AD pathology has been well documented. Poor nutritional status accelerates progress potentially aggravating amyloid beta (Aβ) tau deposition, exacerbating oxidative stress response, modulating microbiota–gut–brain axis, disrupting blood–brain barrier function. advanced stage tends to lead malnutrition due impairments, sensory dysfunctions, brain atrophy, behavioral psychological symptoms dementia (BPSD). This, in turn, produces vicious cycle AD. This review discusses how factors deteriorate each other from early terminal stages AD, focusing on potential different levels factors, ranging micronutrients diet patterns. provides novel insights into reducing risk delaying its progression, improving prognosis. Highlights Two‐fifths cases worldwide have attributed modifiable factors. Up ≈26% community‐dwelling patients with are malnourished, compared 7%∼76% institutionalized patients. Undernutrition effects onset, prognosis through multiple mechanisms. Various supports were confirmed be protective for via specific

Язык: Английский

Процитировано

1

Resveratrol: A Review on the Biological Activity and Applications DOI Creative Commons

Ludovic Everard Bejenaru,

Andrei Biţă,

Ionela Belu

и другие.

Applied Sciences, Год журнала: 2024, Номер 14(11), С. 4534 - 4534

Опубликована: Май 25, 2024

Resveratrol (RSV), a naturally occurring phytoalexin, is the most important stilbenoid synthesized by plants as defense mechanism in response to microbial aggression, toxins, or ultraviolet radiation. RSV came attention of researchers both potential chemopreventive agent and possible explanation for low incidence cardiovascular disease (CVD) French people with high-fat diet. mainly administered food supplement, its properties are evaluated vitro vivo on various experimental models. modulates signaling pathways that limit spread tumor cells, protects nerve cells from damage, useful prevention diabetes, generally acts an anti-aging natural compound. It was highlighted could ameliorate consequences unhealthy lifestyle caused exaggerated caloric intake. This paper reviews evidence supporting beneficial effect pathological conditions, e.g., neoplastic diseases, neurodegeneration, metabolic syndrome, obesity, CVDs, immune bacterial, viral, fungal infections. The study also focused chromatographic analysis trans-RSV (tRSV) Romanian wine samples, providing comprehensive overview tRSV content across different types wine.

Язык: Английский

Процитировано

7

Pharmacological Activities and Molecular Mechanisms of Sinapic Acid in Neurological Disorders DOI
Mahan Farzan,

Behnaz Abedi,

Iman Bhia

и другие.

ACS Chemical Neuroscience, Год журнала: 2024, Номер 15(16), С. 2966 - 2981

Опубликована: Июль 31, 2024

Sinapic acid (SA) is a phenylpropanoid derivative found in various natural sources that exhibits remarkable versatile properties, including antioxidant, anti-inflammatory, and metal-chelating capabilities, establishing itself as promising candidate for the prevention treatment of conditions affecting central nervous system, such Alzheimer's disease (AD), Parkinson's (PD), ischemic stroke, other neurological disorders. These effects also include neuroprotection epilepsy models, evidenced by reduction seizure-like behavior, cell death specific hippocampal regions, lowered neuroinflammatory markers. In AD, SA enhances memory, reverses cognitive deficits, attenuates astrocyte activation. has positive on cognition improving memory lowering oxidative stress. This shown lower levels stress markers, higher antioxidant enzyme activity, better retention. Additionally, stroke PD provides microglial protection exerts anti-inflammatory effects. review emphasizes SA's multifaceted neuroprotective properties its potential role brain Despite need further research to fully understand mechanisms action clinical applicability, stands out valuable bioactive compound ongoing quest combat neurodegenerative diseases enhance quality life affected individuals.

Язык: Английский

Процитировано

5

Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer’s Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids DOI Open Access
Mahsa Yavari, Nishan S. Kalupahana, Breanna N. Harris

и другие.

Nutrients, Год журнала: 2025, Номер 17(7), С. 1203 - 1203

Опубликована: Март 29, 2025

Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline, memory loss, and behavioral changes. It poses significant global health challenge. AD associated with the accumulation of amyloid-β (Aβ) plaques neurofibrillary tangles (NFTs) in brain, along chronic inflammation, dysfunctional neurons, synapse loss. While prevalence continues to rise, current FDA-approved drugs offer only limited effectiveness. Emerging evidence suggests that obesity, insulin resistance (IR), type 2 diabetes mellitus (T2DM) are also implicated pathogenesis, epidemiological studies animal models confirming impact IR on Aβ accumulation, high-fat diets exacerbating accumulation. Since neuroinflammation activated involves nuclear factor kappa-light-chain-enhancer B cell (NF-κB) pathway, inhibition NF-κB NLRP3 inflammasome activation potential therapeutic strategies AD. Bioactive compounds, including polyphenols (resveratrol, epigallocatechin-3-gallate, curcumin, quercetin), omega-3 polyunsaturated fatty acids, show promising results clinical trials for reducing levels, improving cognition modulating signaling pathways This review explores interplay between IR, pathology, emphasizing dietary compounds their role oxidative stress, as viable prevention treatment. By integrating findings, observational studies, trials, this aims provide comprehensive understating how metabolic dysfunctions bioactive influence progression.

Язык: Английский

Процитировано

0

Resveratrol: A Review on the Biological Activity and Applications DOI Open Access

Ludovic Everard Bejenaru,

Andrei Biţă,

Ionela Belu

и другие.

Опубликована: Апрель 30, 2024

Resveratrol (RSV), a naturally occurring phytoalexin, is the most important stilbenoid synthesized by plants, as defense mechanism, in response to microbial aggression, toxins or ultraviolet radiation. RSV came attention of researchers both potential chemopreventive agent and possible explanation for low incidence cardiovascular disease (CVD) French people with high-fat diet. mainly administered food supplement, its properties being evaluated vitro vivo, on various experimental models. modulates signaling pathways that limit spread tumor cells, protects nerve cells from damage, useful prevention diabetes, generally acts an anti-aging natural compound. It was highlighted could ameliorate consequences unhealthy lifestyle caused exaggerated caloric intake. This paper reviews evidence supporting beneficial effect pathological conditions, e.g., neoplastic diseases, neurodegeneration, metabolic syndrome, obesity, CVDs, immune bacterial, viral, fungal infections. The study also focused chromatographic analysis trans-RSV (tRSV) Romanian wine samples, providing comprehensive overview tRSV content across different types wine.

Язык: Английский

Процитировано

4

Targeting Gut Microbiota with Probiotics and Phenolic Compounds in the Treatment of Atherosclerosis: A Comprehensive Review DOI Creative Commons

José Patrocínio Ribeiro Cruz Neto,

Micaelle Oliveira de Luna Freire, Deborah Emanuelle de Albuquerque Lemos

и другие.

Foods, Год журнала: 2024, Номер 13(18), С. 2886 - 2886

Опубликована: Сен. 12, 2024

Atherosclerosis (AS) is a chronic inflammatory vascular disease. Dysregulated lipid metabolism, oxidative stress, and inflammation are the major mechanisms implicated in development of AS. In addition, evidence suggests that gut dysbiosis plays an important role atherogenesis, modulation microbiota with probiotics phenolic compounds has emerged as promising strategy for preventing treating It been shown can improve atherosclerosis-related parameters by improving profile, inflammation. these may modulate diversity composition atherosclerosis. The studies evaluated present review showed compounds, when consumed individually, improved atherosclerosis modulating various ways, such decreasing permeability, TMAO LPS levels, altering alpha beta diversity, increasing fecal bile acid loss. However, no study was found combined use to available literature highlights synergistic potential between their health-promoting properties functionalities. This aims summarize on individual effects AS, while providing insights into benefits nutraceutical approaches using probiotic strains, quercetin, resveratrol adjuvant therapies AS treatment through microbiota.

Язык: Английский

Процитировано

4

The Nrf2-HO-1 system and inflammaging DOI Creative Commons
Sinead A O’Rourke, Lianne C. Shanley, Aisling Dunne

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Сен. 24, 2024

Nrf2 is a master transcriptional regulator of number genes involved in the adaptive response to oxidative stress. Among upregulated by Nrf2, heme oxygenase-1 (HO-1) has received significant attention, given that products HO-1-induced catabolism have well established antioxidant and anti-inflammatory properties. This evidenced numerous models inflammatory autoimmune disease whereby induction HO-1 expression or administration tolerable amounts reaction can ameliorate symptoms. Unsurprisingly, are now considered viable drug targets for conditions. In recent years, term ‘inflammaging’ been used describe low-grade chronic inflammation observed aging/aged cells. Increased stress also key factor associated with aging there convincing evidence not only declines age, but reduce cellular senescence senescence-associated secretory phenotype (SASP) which an underlying driver age-related disease. this review, we role highlight potential anti-aging properties Nrf2-HO-1 system. We newly emerging activators their therapeutic application

Язык: Английский

Процитировано

4

Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases DOI Creative Commons
Dan Chen,

Yun Sun

Journal of Integrative Neuroscience, Год журнала: 2025, Номер 24(1)

Опубликована: Янв. 20, 2025

Alzheimer’s disease (AD) is a common central neurodegenerative disorder characterized primarily by cognitive impairment and non-cognitive neuropsychiatric symptoms that significantly impact patients’ daily lives behavioral functioning. The pathogenesis of AD remains unclear current Western medicines treatment are purely symptomatic, with singular pathway, limited efficacy, substantial toxicity side effects. In recent years, as research into has deepened, there been gradual increase in the exploration application medicinal plants for AD. Numerous studies have shown their active ingredients can potentially mitigate regulating various molecular mechanisms, including production aggregation pathological proteins, oxidative stress, neuroinflammation, apoptosis, mitochondrial dysfunction, neurogenesis, neurotransmission, brain-gut microbiota axis. this review, we analyzed comprehensively summarized advancements on AD, along underlying mechanisms clinical evidence. Ultimately, aimed to provide reference further investigation specific through which prevent treat well identification efficacious derived from plants.

Язык: Английский

Процитировано

0

Exploring Quinazoline as a Scaffold for Developing Novel Therapeutics in Alzheimer’s Disease DOI Creative Commons
Qais Abualassal, Zead Abudayeh,

Ala’ Yahya Sirhan

и другие.

Molecules, Год журнала: 2025, Номер 30(3), С. 555 - 555

Опубликована: Янв. 26, 2025

Quinazoline, a privileged scaffold in medicinal chemistry, offers promising potential the synthesis of anti-Alzheimer’s disease (AD) drugs. This heterocyclic compound, characterized by its fused benzene and pyrimidine rings, enables design multifunctional agents targeting AD pathology. The drug-like aspects pharmaceutical features quinazoline derivatives have to give rise various therapeutic is progressive neurodegenerative condition marked memory decline, cognitive deterioration, language disorders. Given complexity multifaceted nature, there pressing need discover multi-target drugs effectively address this debilitating disorder. A comprehensive literature review has demonstrated that exhibit wide range for AD. These compounds function as inhibitors cholinesterases, β-amyloid aggregation, oxidative stress, tau protein, among other protective effects. Here, we highlight most significant recent research on quinazoline-based anti-AD agents, aiming support development discovery novel treatments

Язык: Английский

Процитировано

0

Pharmacological and Therapeutic Innovation to Mitigate Radiation-Induced Cognitive Decline (RICD) in Brain Tumor Patients DOI

Jemema Agnes Tripena Raj,

Janmay Shah,

Smita V. Ghanekar

и другие.

Cancer Letters, Год журнала: 2025, Номер unknown, С. 217700 - 217700

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0